US Broker Ratings

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 64.34% Potential Upside in the Healthcare Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) is making waves in the healthcare sector with its innovative approach to tackling obstructive sleep apnea (OSA). With a market..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Unlocking a Potential 28.25% Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector, focuses on designing and manufacturing single-use medical products critical for interventional, diagnostic, and..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Compelling 190% Upside Potential

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is capturing the attention of investors with its remarkable upside potential. As a clinical-stage biopharmaceutical company, Soleno is focused on developing..

Guardant Health, Inc. (GH) Stock Analysis: A Precision Oncology Pioneer with 9.82% Upside Potential

Guardant Health, Inc. (NASDAQ: GH), a leader in the precision oncology space, has been catching the eye of investors with its innovative approach in diagnostics and..

Grifols, S.A. (GRFS)

⚠️ No article content returned.

..

Hologic, Inc. (HOLX) Stock Analysis: Unpacking Growth Potential Amidst a Hold Rating Consensus

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, specializes in medical instruments and supplies with a particular focus on women’s health. With a..

Avantor, Inc. (AVTR) Investor Outlook: Evaluating a 19.37% Potential Upside Amidst Sector Challenges

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, is currently drawing attention from investors due to its potential upside of 19.37%, according to..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Navigating Growth in Biotechnology with a 3.39% Potential Upside

Akero Therapeutics, Inc. (NASDAQ: AKRO) has emerged as a prominent player in the biotechnology sector, focusing on developing innovative treatments for serious metabolic diseases. With a..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Navigating the Upside with a Potential 2.85% Gain

Avidity Biosciences, Inc. (NASDAQ: RNA) stands at the forefront of a revolutionary approach in biotechnology, leveraging its proprietary antibody oligonucleotide conjugates (AOCs) platform to address previously..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Uncovering a 38% Potential Upside in the Biotech Sector

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is gaining attention from investors with its promising potential upside of 38.09%. This commercial-stage biopharmaceutical company, headquartered in Boston, is pioneering..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth and Challenges in the Healthcare Sector

Charles River Laboratories International, Inc. (NYSE: CRL) stands at a pivotal juncture in the healthcare sector, offering a fascinating blend of opportunity and challenge for investors...

Bausch + Lomb Corporation (BLCO): Investor Outlook on Eye Health Giant with a 5% Upside

Bausch + Lomb Corporation (BLCO), a renowned name in the healthcare sector, specifically within the medical instruments and supplies industry, presents a compelling investment opportunity with..

BrightSpring Health Services, I (BTSG) Stock Analysis: A Promising 12.38% Upside in the Healthcare Sector

BrightSpring Health Services, Inc. (BTSG) stands as a formidable player within the U.S. healthcare sector, specifically in the realm of Health Information Services. Operating primarily through..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Exploring the 52.42% Potential Upside and Strategic Positioning in Biotechnology

TG Therapeutics, Inc. (NASDAQ: TGTX) has become a notable player in the biotechnology sector, capturing investor attention with its promising portfolio of treatments for B-cell mediated..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Revenue Growth and Analyst Optimism Signal Investment Potential

Cardinal Health, Inc. (NYSE: CAH) has positioned itself as a formidable player in the healthcare sector, specifically within the medical distribution industry. With a substantial market..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Evaluating the 19.27% Potential Upside in Precision Oncology

Revolution Medicines, Inc. (NASDAQ: RVMD) is a clinical-stage biotechnology company making significant strides in the healthcare sector by focusing on precision oncology. Headquartered in Redwood City,..

HealthEquity, Inc. (HQY) Investor Outlook: Unpacking a 39% Potential Upside

As the leading provider of health savings accounts (HSAs) and other consumer-directed benefits, HealthEquity, Inc. (NASDAQ: HQY) is capturing significant attention in the healthcare sector. With..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 24.72% Upside Potential in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH) is making waves in the healthcare sector, and for good reason. With a strong focus on diagnostic and therapeutic products, the..

Bio-Techne Corp (TECH) Stock Analysis: Unpacking the 9.22% Potential Upside Amidst Mixed Performance Metrics

Bio-Techne Corporation (NASDAQ: TECH) stands as a notable player in the biotechnology sector, with a robust presence in the healthcare industry. Valued at a market capitalization..

GSK plc (GSK) Stock Analysis: Navigating Market Leadership with Robust Dividend Yield and Strategic Collaborations

GSK plc (NYSE: GSK), a stalwart in the global healthcare landscape, is showing promising indicators for investors seeking a blend of stable income and potential growth...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds